Literature DB >> 21897041

UVC mutagenicity is suppressed in Japanese miso-treated human RSa cells, possibly via GRP78 expression.

Xia Jiang1, Qian Ren, Shi-Ping Chen, Xiao-Bo Tong, Mei Dong, Shigeru Sugaya, Takeshi Tanaka, Kazuko Kita, Nobuo Suzuki.   

Abstract

Little is known about the ability of miso, to modulate mutability in human cells. We have observed increased levels of glucose-regulated protein 78 (GRP78) expression in association with suppression of mutation in human RSa cells irradiated with ultraviolet C (UVC). Here we examined to determine whether miso treatment results in increased GRP78 expression and suppression of UVC mutagenicity in RSa cells. Supernatants of water extracts of miso products and their components were tested. In the sample-treated cells, the amount of GRP78, as estimated by RT-PCR and immunoblotting analysis, increased, and the UVC-induced ouabain resistant mutation (Oua(R)) and the K-ras codon 12-base substitution mutation frequency decreased. This decrease was not observed in cells with downregulation of GRP78 by GRP78 siRNA transfection. The results suggest that miso suppresses UVC mutagenicity by increasing GRP78 expression in human cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21897041     DOI: 10.1271/bbb.110175

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  2 in total

1.  Inhibitory effect of Japanese rice-koji miso extracts on hepatitis A virus replication in association with the elevation of glucose-regulated protein 78 expression.

Authors:  Nan Nwe Win; Tatsuo Kanda; Shingo Nakamoto; Mitsuhiko Moriyama; Xia Jiang; Akiko Suganami; Yutaka Tamura; Hiroaki Okamoto; Hiroshi Shirasawa
Journal:  Int J Med Sci       Date:  2018-07-30       Impact factor: 3.738

2.  Involvement of heat shock protein 27 in the susceptibility of KT human breast cancer cells to UVC and interferon lethality.

Authors:  Xiao-Bo Tong; Kazuko Kita; Shi-Ping Chen; Xia Jiang; Shigeru Sugaya; Wen-Li Jing; Shu-Feng Zhang; Nobuo Suzuki
Journal:  Exp Ther Med       Date:  2012-09-04       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.